CardioGenics Holdings (CardioGenics Holdings) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 07, 2024)

CardioGenics Holdings Intrinsic Value: Projected FCF Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Intrinsic Value: Projected FCF		Get a 7-Day Free Trial					-0.05	-0.08	-0.11	-0.11	-0.08

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Intrinsic Value: Projected FCF	Get a 7-Day Free Trial															-0.10	-0.07	-0.08	-0.08	-0.06

Competitive Comparison of CardioGenics Holdings's Intrinsic Value: Projected FCF

For the Diagnostics & Research subindustry, CardioGenics Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Price-to-Projected-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Price-to-Projected-FCF falls into.

CardioGenics Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)

Add all the Free Cash Flow together and divide 6 will get CardioGenics Holdings's Free Cash Flow(6 year avg) = $-1.06.

CardioGenics Holdings's Intrinsic Value: Projected FCF for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings  (OTCPK:CGNH) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

CardioGenics Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description